Article

AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters

Author(s):

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

AstraZeneca has proposed designs for its new Global R&D center and corporate headquarters in Cambridge, UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the global center, an R&D enabling building, and an energy center.

The new site will bring together AstraZeneca’s small molecule and biologics research and development activity, opening up more opportunities for biologics and small molecule combinations. The CBC will be the new UK home for biologics research and protein engineering carried out by MedImmune, AstraZeneca’s biologics arm. MedImmune currently employs around 500 people at Granta Park, to the southeast of the city.

In advance of the new site to be finished in late 2016, around 70 AstraZeneca staff have already relocated to interim facilities in Cambridge, at the Melbourn Science Park, Cambridge Science Park, and Granta Park. By the end of 2014 approximately 300­–400 AstraZeneca staff will have relocated to the city.

Designs for AstraZeneca’s new site are being made available as part of a public consultation for the local community, ahead of submission of a detailed planning application in autumn 2014. AstraZeneca expects to begin building the new site in early 2015.

Source: AstraZeneca

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content